Ugorski M, Blackall D P, Påhlsson P, Shakin-Eshleman S H, Moore J, Spitalnik S L
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104.
Blood. 1993 Sep 15;82(6):1913-20.
Glycophorin A is a heavily glycosylated glycoprotein (1 N-linked and 15 O-linked oligosaccharides) and is highly expressed on the surface of human red blood cells. It is important in transfusion medicine because it carries several clinically relevant human blood group antigens. To study further the role of glycosylation in surface expression of this protein, four mutations were separately introduced into glycophorin A cDNA by site-directed mutagenesis. Each of these mutations blocks N-linked glycosylation at Asn26 of this glycoprotein by affecting the Asn-X-Ser/Thr acceptor sequence. Two of these mutations are identical to the amino acid polymorphisms found at position 28 in the Mi.I and Mi.II Miltenberger blood group antigens. The mutated recombinant glycoproteins were expressed in transfected wild-type and glycosylation-deficient Chinese hamster ovary (CHO) cells. When expressed in wild-type CHO cells and analyzed on Western blots, each of the four mutants had a faster electrophoretic mobility than wild-type glycophorin A, corresponding to a difference of approximately 4 Kd. This change is consistent with the absence of the N-linked oligosaccharide at Asn26. Each of the four mutants was highly expressed on the surface of CHO cells, confirming that, in the presence of normal O-linked glycosylation, the N-linked oligosaccharide is not necessary for cell surface expression of this glycoprotein. To examine the role of O-linked glycosylation in this process, the Mi.I mutant cDNA was transfected into the IdlD glycosylation-deficient CHO cell line. When the transfected IdlD cells were cultured in the presence of N-acetylgalactosamine alone, only intermediate levels of cell surface expression were seen for Mi.I mutant glycophorin A containing truncated O-linked oligosaccharides. In contrast, when cultured in the presence of galactose alone, or in the absence of both galactose and N-acetylgalactosamine, Mi.I mutant glycophorin A lacking both N-linked and O-linked oligosaccharides was not expressed at the cell surface. This extends previous results (Remaley et al, J Biol Chem 266:24176, 1991) showing that, in the absence of O-linked glycosylation, some types of N-linked glycosylation can support cell surface expression of glycophorin A. The glycophorin A mutants were also used for serologic testing with defined human antisera. These studies showed that the recombinant Mi.I and Mi.II glycoproteins appropriately bound anti-Vw and anti-Hut, respectively. They also demonstrated that these antibodies recognized the amino acid polymorphisms encoded by Mi.I and Mi.II rather than cryptic peptide antigens uncovered by the lack of N-linked glycosylation.
血型糖蛋白A是一种高度糖基化的糖蛋白(1个N-连接和15个O-连接寡糖),在人类红细胞表面高度表达。它在输血医学中很重要,因为它携带几种临床相关的人类血型抗原。为了进一步研究糖基化在该蛋白表面表达中的作用,通过定点诱变将四个突变分别引入血型糖蛋白A的cDNA中。这些突变中的每一个都通过影响Asn-X-Ser/Thr接受序列来阻断该糖蛋白Asn26处的N-连接糖基化。其中两个突变与在Mi.I和Mi.II密尔滕贝格血型抗原第28位发现的氨基酸多态性相同。突变的重组糖蛋白在转染的野生型和糖基化缺陷型中国仓鼠卵巢(CHO)细胞中表达。当在野生型CHO细胞中表达并在蛋白质印迹上分析时,四个突变体中的每一个都比野生型血型糖蛋白A具有更快的电泳迁移率,相当于约4 Kd的差异。这种变化与Asn26处不存在N-连接寡糖一致。四个突变体中的每一个都在CHO细胞表面高度表达,证实了在正常O-连接糖基化存在的情况下,N-连接寡糖对于该糖蛋白的细胞表面表达不是必需的。为了研究O-连接糖基化在此过程中的作用,将Mi.I突变体cDNA转染到IdlD糖基化缺陷型CHO细胞系中。当转染的IdlD细胞仅在N-乙酰半乳糖胺存在下培养时,对于含有截短O-连接寡糖的Mi.I突变体血型糖蛋白A,仅观察到中等水平的细胞表面表达。相反,当仅在半乳糖存在下培养,或在半乳糖和N-乙酰半乳糖胺两者都不存在的情况下培养时,缺乏N-连接和O-连接寡糖的Mi.I突变体血型糖蛋白A不在细胞表面表达。这扩展了先前的结果(Remaley等人,《生物化学杂志》266:24176,1991),表明在没有O-连接糖基化的情况下,某些类型的N-连接糖基化可以支持血型糖蛋白A的细胞表面表达。血型糖蛋白A突变体也用于用特定的人抗血清进行血清学检测。这些研究表明,重组的Mi.I和Mi.II糖蛋白分别适当地结合抗-Vw和抗-Hut。它们还证明这些抗体识别由Mi.I和Mi.II编码的氨基酸多态性,而不是由于缺乏N-连接糖基化而暴露的隐蔽肽抗原。